Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48K Hold
103
﹤0.01% 717
2026
Q1
$38.9K Hold
103
﹤0.01% 736
2025
Q4
$44.1K Hold
103
﹤0.01% 716
2025
Q3
$46.1K Buy
103
+27
+36% +$12.2K ﹤0.01% 708
2025
Q2
$37K Buy
76
+28
+58% +$16K ﹤0.01% 697
2025
Q1
$29.5K Buy
+48
New +$27.3K ﹤0.01% 734
2022
Q3
Sell
-12
Closed -$6K 990
2022
Q2
$6K Buy
+12
New +$5.85K ﹤0.01% 868

Other funds holding CHE

HM Payson & Co's CHE Position: Q2 2026 in Review

HM Payson & Co held its Chemed (CHE) position steady in Q2 2026 at 103 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #717.

HM Payson & Co first reported a position in CHE in Q2 2022 and has held it in 7 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • HM Payson & Co held 103 shares of Chemed worth $48K as of Q2 2026.
  • HM Payson & Co left its Chemed share count unchanged in Q2 2026.
  • Chemed made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #717 holding.
  • HM Payson & Co first reported a position in Chemed in Q2 2022 and has held it in 7 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.